Enbrel 50 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26F97V9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,299
Award facts
- Contract value 100% obligated
- $10,299.18 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $10,299.18 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 26, 2026, for the supply of Enbrel 50 mg/mL SureClick auto-injectors. This contract, which is not set-aside, will be performed at the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of January 27, 2026. The award represents a task order executed under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for delivering comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally.
Enbrel is a biologic immunosuppressant medication used to treat autoimmune conditions such as rheumatoid arthritis, and the SureClick delivery system is a pre-filled auto-injector that enhances patient convenience and medication adherence. This delivery order exemplifies the critical pharmaceutical supply chain support that AmerisourceBergen provides to the Department of Defense and military treatment facilities. The competitively awarded contract demonstrates the contractor's established capability to meet federal procurement requirements for specialty pharmaceutical products across multiple therapeutic domains that support the healthcare needs of active-duty service members, military beneficiaries, and veterans.
Quick answers
Who was awarded contract SPE2DR26F97V9?
SPE2DR26F97V9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 26, 2026.
How much is contract SPE2DR26F97V9 worth?
The government has obligated $10,299 on SPE2DR26F97V9.
Is contract SPE2DR26F97V9 an order under another contract?
Yes. SPE2DR26F97V9 is a delivery order under SPE2DR25D3505, an indefinite delivery contract.
Was contract SPE2DR26F97V9 competed?
The extent of competition for SPE2DR26F97V9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award